Unexpectedly, there is an increase of DMPK expression in cells of congenital DM1 individuals that present increased CpG methylation of CTCF-binding sites flanking the (CTG)n substantially reducing binding of CTCFs [197]. The gene discussed is DMPK; the disease is myotonic dystrophy type 1.